Searching map area
Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab
? TBD
scientific article
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Author
Iris Nagtegaal
Subject
Patient
Colorectal cancer
Cetuximab
metastatic colon cancer
colorectal carcinoma
References
Wikidata